Heart patients are often not treated in accordance with guidelines

NewsGuard 100/100 Score

Many patients with cardiovascular disease are not given adequate drug therapy.

This is the result of an international study. In the current edition of Deutsches Ärzteblatt International ( Dtsch Arztebl Int 2008; 105[45]: 769-75), Uwe Zeimer et al. present the German results of this prospective, one-year survey.

512 doctors in Germany took part in the study. They enrolled 5594 patients in all, of whom 89.2% suffered from one or more cardiovascular diseases and 10.8% only exhibited risk factors. Documented risk factors included high blood pressure, disturbances in lipid metabolism, diabetes, and obesity. The results showed that several vascular beds were affected simultaneously in almost one third of patients. Many patients also suffered from other diseases requiring treatment, which were defined as risk factors. After one year, 2.1% of the patients with cardiovascular disease and 1.5% of the patients with at least three risk factors had died.

The study demonstrated that only three quarters of patients were given drugs to reduce fat levels. The same proportion was given drugs to dilute blood. Moreover, the doctors failed to exhaust the possibilities for drug treatment. This may be the reason that 27% of the patients with high blood pressure failed to reach the target blood pressure and 66% of the patients with disturbances in lipid metabolism failed to reach the target cholesterol level.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Linking lifestyle to longevity: How diet and hypertension sway risks for heart disease and cancer